Latest Breaking News On - Prnewswire cardiff oncology inc - Page 3 : comparemela.com

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

James levineRicha kumariKiki patelGilmartin groupPrnewswire cardiff oncology incTaft communicationsCardiff oncology incCardiff oncologyNasdaq listing ruleOncology contact

Cardiff Oncology Formally Introduces Scientific Advisory Board

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug.

Region flamandeUnited statesIsrael generalHeinz josef lenzScott kopetzAdam schayowitzRicha kumariEli lillyJames levineChristoph reinhardKiki patelFairooz kabbinavarJosep taberneroCellphenomics gmbEric van cutsemVan cutsem

Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug.

Joyce allaireJames levineCardiff oncology incGi gu oncology panel discussionPrnewswire cardiff oncology incHealth care conferenceAnnual health care conferenceBoston marriott copley placeCardiff oncologyOncology contact

Cardiff Oncology to Present at Upcoming Investor Conferences

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

New yorkUnited statesJoyce allaireJames levineCardiff oncology incPrnewswire cardiff oncology incAnnual piper sandler healthcare conferenceOncology summitCardiff oncologyOncology contact

Cardiff Oncology to Present at the Jefferies London Healthcare Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

United kingdomCity ofJoyce allaireJames levineCardiff oncology incPrnewswire cardiff oncology incJefferies london healthcare conferenceCardiff oncologyOncology contactHealth care amp hospitalsMedical pharmaceuticalsConference call announcementsTrade show news